Transformation or replacement - Effects of hormone therapy on cardiovascular risk

被引:1
|
作者
Kielb, Julia [1 ,4 ,5 ]
Weber, Jessica [1 ,4 ,5 ]
Baensch, Leonard [1 ,4 ]
Shahjerdi, Khatereh [1 ,4 ]
Celik, Aylin [1 ,4 ]
Farahat, Nora [1 ,4 ]
Riek, Sally [1 ,4 ]
Chavez-Talavera, Oscar [1 ,4 ]
Grandoch, Maria [2 ,3 ]
Polzin, Amin [1 ,4 ]
Kelm, Malte [1 ,4 ]
Dannenberg, Lisa [1 ,4 ,5 ]
机构
[1] Heinrich Heine Univ Dusseldorf, Dept Cardiol Pulmonol & Vasc Med, Med Fac, Dusseldorf, Germany
[2] Heinrich Heine Univ Dusseldorf, Inst Translat Pharmacol, Med Fac, Dusseldorf, Germany
[3] Heinrich Heine Univ Dusseldorf, Univ Hosp Dusseldorf, Dusseldorf, Germany
[4] Cardiovasc Res Inst Dusseldorf CARID, Dusseldorf, Germany
[5] Univ Hosp Dusseldorf, Dept Cardiol Pneumol & Vasc Med, Moorenstr 5, D-40225 Dusseldorf, Germany
关键词
Hormone therapy; Cardiovascular risk; Menopause; Transgender; VASCULAR ENDOTHELIAL-CELLS; ESTROGEN PLUS PROGESTIN; TESTOSTERONE THERAPY; MYOCARDIAL-INFARCTION; MEDROXYPROGESTERONE ACETATE; PLATELET-AGGREGATION; POSTMENOPAUSAL WOMEN; TRANSGENDER MEN; IN-VITRO; RECEPTOR;
D O I
10.1016/j.pharmthera.2024.108592
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Hormone therapy (HT) is important and frequently used both regarding replacement therapy (HRT) and gender affirming therapy (GAHT). While HRT has been effective in addressing symptoms related to hormone shortage, several side effects have been described. In this context, there are some studies that show increased cardiovascular risk. However, there are also studies reporting protective aspects of HT. Nevertheless, the exact impact of HT on cardiovascular risk and the underlying mechanisms remain poorly understood. This article explores the relationship between diverse types of HT and cardiovascular risk, focusing on mechanistic insights of the underlying hormones on platelet and leukocyte function as well as on effects on endothelial and adipose tissue cells. (c) 2024 Elsevier Inc. All rights reserved.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Effects of menopausal hormone replacement therapy on cardiovascular risk
    Kuttenn, F
    Gerson, M
    de Lignères, B
    PRESSE MEDICALE, 2002, 31 (10): : 468 - 475
  • [2] Cardiovascular risk and hormone replacement therapy
    Lawlor, Debbie A.
    Smith, George Davey
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2006, 18 (06) : 658 - 665
  • [3] Hormone replacement therapy and cardiovascular risk
    Gerhard-Herman M.
    Hamburg N.
    Ganz P.
    Current Cardiology Reports, 2000, 2 (4) : 288 - 292
  • [4] Cardiovascular risk and hormone replacement therapy
    Rabe, T
    Grunwald, K
    Vladescu, E
    Runnebaum, B
    GYNAKOLOGE, 1998, 31 (10): : 859 - 869
  • [5] HORMONE REPLACEMENT THERAPY AND CARDIOVASCULAR RISK
    LIP, GYH
    LANCET, 1995, 345 (8949): : 585 - 586
  • [6] Hormone replacement therapy and cardiovascular risk
    Plu-Bureau, G
    THERAPIE, 1999, 54 (03): : 375 - 380
  • [7] Effects of hormone replacement therapy on hemostatic cardiovascular risk factors
    Andersen, LF
    Gram, J
    Skouby, SO
    Jespersen, J
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 180 (02) : 283 - 289
  • [8] Effects of hormone replacement therapy on cardiovascular risk factors in postmenopausal women
    Chen, FP
    Lee, N
    Wang, CH
    Cherng, WJ
    Soong, YK
    FERTILITY AND STERILITY, 1998, 69 (02) : 267 - 273
  • [9] Cardiovascular Risk from Hormone Replacement Therapy
    Johansson
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2025, 150 (04) : 125 - 125
  • [10] Cardiovascular Risk in Growth Hormone Deficiency Beneficial Effects of Growth Hormone Replacement Therapy
    Lanes, Roberto
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2016, 45 (02) : 405 - +